ZA866025B - Injectable semi-solid formulations - Google Patents

Injectable semi-solid formulations

Info

Publication number
ZA866025B
ZA866025B ZA866025A ZA866025A ZA866025B ZA 866025 B ZA866025 B ZA 866025B ZA 866025 A ZA866025 A ZA 866025A ZA 866025 A ZA866025 A ZA 866025A ZA 866025 B ZA866025 B ZA 866025B
Authority
ZA
South Africa
Prior art keywords
solid formulations
injectable semi
injectable
semi
formulations
Prior art date
Application number
ZA866025A
Other languages
English (en)
Inventor
Arvind Lavji Thakkar
Roger Garrick Harrison
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA866025B publication Critical patent/ZA866025B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA866025A 1985-08-19 1986-08-11 Injectable semi-solid formulations ZA866025B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/766,725 US4775659A (en) 1985-08-19 1985-08-19 Injectable semi-solid formulations

Publications (1)

Publication Number Publication Date
ZA866025B true ZA866025B (en) 1988-04-27

Family

ID=25077329

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA866025A ZA866025B (en) 1985-08-19 1986-08-11 Injectable semi-solid formulations

Country Status (12)

Country Link
US (1) US4775659A (xx)
EP (1) EP0213851B1 (xx)
JP (1) JPH0710781B2 (xx)
AU (1) AU596806B2 (xx)
CA (1) CA1269933A (xx)
DE (1) DE3684386D1 (xx)
DK (1) DK386986A (xx)
IE (1) IE59130B1 (xx)
IL (1) IL79683A (xx)
NZ (1) NZ217176A (xx)
PH (1) PH23476A (xx)
ZA (1) ZA866025B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL79765A (en) * 1985-08-23 1992-02-16 Lilly Co Eli Injectable sustained release formulations of bovine somatotropin
CA1257199A (en) * 1986-05-20 1989-07-11 Paul Y. Wang Preparation containing bioactive macromolecular substance for multi-months release in vivo
GB8725427D0 (en) * 1987-10-30 1987-12-02 Lilly Industries Ltd Somatotropin formulations
US5179080A (en) * 1989-08-31 1993-01-12 Clinical Homecare, Corp. Formulations containing growth hormone and nutritional supplements, and methods of treating malnutrition in chronic lung disease
AU652022B2 (en) * 1991-02-12 1994-08-11 C.R. Bard Inc. Injectable medical device
YU87892A (sh) * 1991-10-01 1995-12-04 Eli Lilly And Company Lilly Corporate Center Injektibilne formulacije produženog otpuštanja i postupci za njihovo dobijanje i primenu
US5629008A (en) * 1992-06-02 1997-05-13 C.R. Bard, Inc. Method and device for long-term delivery of drugs
SE9202128D0 (sv) * 1992-07-09 1992-07-09 Astra Ab Precipitation of one or more active compounds in situ
US5559110A (en) * 1994-03-09 1996-09-24 The Dupont Merck Pharmaceutical Company Pharmaceutical formulations of cyclic urea type compounds
ZA9711731B (en) * 1996-12-31 1998-07-01 Monsanto Co Aqueous glycerol formulations of somatotropin
KR19990071255A (ko) 1998-02-28 1999-09-15 성재갑 소마토트로핀과 비타민의 합제 조성물
KR101768843B1 (ko) 2013-02-28 2017-08-17 미라 파마 코포레이션 주사가능 장기-작용 국소 마취제 반고체 제형 및 이의 조성물
US10220093B2 (en) 2013-02-28 2019-03-05 Mira Pharma Corporation Long-acting semi-solid lipid formulations
BR102013008990A2 (pt) * 2013-04-12 2014-12-30 Ouro Fino Participacoes E Empreendimentos S A Composições farmacêuticas compreendendo kisspeptina ou seus derivados
US10561606B2 (en) 2017-12-06 2020-02-18 Mira Pharma Corporation Injectable long-acting local anesthetic semi-solid gel formulations
US11426418B2 (en) 2017-12-06 2022-08-30 Mira Pharma Corporation Injectable long-acting semi-solid gel formulations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2493202A (en) * 1946-06-07 1950-01-03 Merck & Co Inc Process of making a fluid oil-beeswax vehicle for the parenteral administration of drugs
FR3658M (fr) * 1964-02-18 1965-11-02 Michel Marie Andre Guerbet Composition huileuse pour l'injection intravasculaire.
BE795516A (fr) * 1972-02-17 1973-08-16 Ciba Geigy Preparations de peptides huileuses et injectables et procede pour leur preparation
SE445174B (sv) * 1978-03-07 1986-06-09 Sandoz Ag Farmaceutisk komposition innehallande en cyklosporin och en berarsubstans
EP0140255B1 (en) * 1983-10-14 1991-05-15 Sumitomo Pharmaceuticals Company, Limited Sustained-release injections
DE3340680A1 (de) * 1983-11-10 1985-05-23 Henkel Kgaa Verfahren zur erhoehung der viskositaet von oelen
ES8702440A1 (es) * 1984-10-04 1986-12-16 Monsanto Co Un procedimiento para la preparacion de una composicion de polipeptido inyectable sustancialmente no acuosa.

Also Published As

Publication number Publication date
CA1269933A (en) 1990-06-05
IE862212L (en) 1987-02-19
US4775659A (en) 1988-10-04
IL79683A0 (en) 1986-11-30
EP0213851B1 (en) 1992-03-18
NZ217176A (en) 1989-06-28
JPS6245538A (ja) 1987-02-27
AU6119986A (en) 1987-02-26
DK386986D0 (da) 1986-08-14
EP0213851A3 (en) 1987-09-02
EP0213851A2 (en) 1987-03-11
IL79683A (en) 1990-11-05
JPH0710781B2 (ja) 1995-02-08
AU596806B2 (en) 1990-05-17
IE59130B1 (en) 1994-01-12
DK386986A (da) 1987-02-20
DE3684386D1 (de) 1992-04-23
PH23476A (en) 1989-08-07

Similar Documents

Publication Publication Date Title
IL78934A (en) Alfuzosine compositions
GB8514052D0 (en) Compositions
GB8619046D0 (en) Compositions
GB8509409D0 (en) Compositions
EP0213851A3 (en) Injectable semi-solid formulations
ZA866218B (en) Injectable sustained release formulation
EP0199235A3 (en) Phenylalkyl-2,3-dihydrobenzofurans and analogs useful as anti-inflammatory agents
GR860123B (en) Compositions
EP0192630A3 (en) Aminomethylenephosphonate compositions
GB8513550D0 (en) Compositions
GB8529409D0 (en) Aminomethylenephosphonate compositions
PH23349A (en) Anti-infective injectable formulations
GB8603048D0 (en) Lymphokine-containing compositions
GB8501400D0 (en) Compositions
GB8520289D0 (en) Compositions
IL93223A0 (en) Formulations comprising 31-azido-31-deoxythymidine
EG17458A (en) Fungicial compositions
GB8523690D0 (en) Formulations
GB8514961D0 (en) Syringes
GB8527416D0 (en) Compositions
GB8514860D0 (en) Compositions
GB8521382D0 (en) Photodegradant compositions
GB8526133D0 (en) Compositions
GB8526499D0 (en) Compositions
GB8526500D0 (en) Compositions